Nano, micro particulate and cosmetic delivery systems of polylactic acid: A mini review

被引:34
作者
Abu Hajleh, Maha N. [1 ]
AL-Samydai, Ali [2 ]
Al-Dujaili, Emad A. S. [3 ]
机构
[1] Al Ahliyya Amman Univ, Fac Allied Med Sci, Dept Cosmet Sci, Amman 19328, Jordan
[2] Al Ahliyya Amman Univ, Pharmacol & Diagnost Res Ctr, Fac Pharm, Amman, Jordan
[3] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
关键词
cosmeticeuticals; microparticles; nanoparticles; L-LACTIC ACID; DRUG-DELIVERY; PLA NANOPARTICLES; BIODEGRADABLE POLYMERS; MICROPARTICLES; FORMULATION; RELEASE; PROTEIN; PLGA;
D O I
10.1111/jocd.13696
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Background Poly lactic acid and its copolymers are considered to be the preferred substrates for drug delivery devices. Poly lactic acid is a biocompatible, biodegradable and nontoxic polymer. It was approved by Food and Drug Administration and thought to be among the most attractive polymeric candidates intended for controlling drug delivery. It was utilized for the development of devices for the delivery of small molecules, proteins, genes, vaccines, anticancer drugs, and macromolecules. Objectives and methods This manuscript lists the different techniques for synthesizing poly lactic acid-based nano and microparticles such as emulsion-based methods, precipitation-based methods, direct compositing methods, in situ forming micro-particles, and microfluidic technique. Conclusions In addition, it describes the application and use of poly lactic acid in biomedical and cosmetic delivery systems.
引用
收藏
页码:2805 / 2811
页数:7
相关论文
共 58 条
[1]
PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[2]
Allouche J., 2013, NANOMATERIALS DANGER, P27, DOI DOI 10.1007/978-1-4471-4213-3-2
[3]
Alsaheb RamziA. Abd., 2015, J CHEM PHARM RES, V7, P51
[4]
Use of Sculptra™ in esthetic rejuvenation [J].
Beer, Kenneth R. ;
Rendon, Marta I. .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2006, 25 (03) :127-131
[5]
Injectable poly-L-lactic acid for cosmetic enhancement: Learning from the European experience [J].
Butterwick, Kimberly ;
Lowe, Nicholas J. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (02) :281-293
[6]
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies [J].
Calzoni, Eleonora ;
Cesaretti, Alessio ;
Polchi, Alice ;
Di Michele, Alessandro ;
Tancini, Brunella ;
Emiliani, Carla .
JOURNAL OF FUNCTIONAL BIOMATERIALS, 2019, 10 (01)
[7]
A Perspective on Polylactic Acid-Based Polymers Use for Nanoparticles Synthesis and Applications [J].
Casalini, Tommaso ;
Rossi, Filippo ;
Castrovinci, Andrea ;
Perale, Giuseppe .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2019, 7
[8]
Drug delivery systems: Advanced technologies potentially applicable in personalized treatments [J].
Coelho J.F. ;
Ferreira P.C. ;
Alves P. ;
Cordeiro R. ;
Fonseca A.C. ;
Góis J.R. ;
Gil M.H. .
EPMA Journal, 2010, 1 (1) :164-209
[9]
Monoclonal antibody-tagged polyethylenimine (PEI)/poly(lactide) (PLA) nanoparticles for the enhanced delivery of doxorubicin in HER-positive breast cancers [J].
Cui, Ning ;
Zhu, Su-Hua .
RSC ADVANCES, 2016, 6 (83) :79822-79829
[10]
Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity [J].
Da Silva, Jessica ;
Jesus, Sandra ;
Bernardi, Natalia ;
Coleco, Mariana ;
Borges, Olga .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2019, 7 (JUN)